Rallybio key facts
as of Oct 2026- It has raised $145.0M across 1 recorded rounds; the latest was Early Stage VC (Series B) ($145.0M) in May 2020.
- 3 institutional filers report fund marks on Rallybio across 8 filings.
- Rallybio has filed 1 Form D with the SEC, most recently Apr 2024 ($6.6M sold to 1 investors).
- ·Watch Rallybio: the Monday email on marks, rounds and moves
Institutional fund marks on Rallybio
3 filers · latest Jul 20263 SEC-registered funds reported 8 fair-value marks on Rallybio between Mar 2026 and Jul 2026. Filer-level marks and implied $/share are available to Pro members.
Membership and data by Private Market View
Rallybio funding rounds
1 roundsRecent activity
In the last 90 days, Rallybio's record added 4 institutional fund marks (latest period Jul 2026).
How much has Rallybio raised?
Rallybio has raised $145 million across 1 recorded round since 2020. The largest was a $145 million Series B in May 2020.
Rallybio has filed 1 Form D with the SEC, most recently in Apr 2024 ($6.6 million sold to 1 investor).
Institutional holders and vehicles
3 SEC-registered funds reported 8 fair-value marks on Rallybio between Mar 2026 and Jul 2026, in their N-PORT filings. Filer-level marks and implied per-share values are available to Pro members.
About Rallybio
- Industry
- Drug Discovery
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.